| Control Peptide for N2912-06 (antiserum) and N2912-07(affinity purified antibody). A 16 AA peptide within the extracellular, N-terminal domain of human NMU Receptor 2 (KLH conjugated). No significant sequence homology exist with other NMUR1, Ghrelin receptors or other proteins. The 16aa human sequence has 85% homology with mouse and rat NMUR2. The neuromedins (Nm) are a family of bioactive peptides best known for their roles in smooth muscle contraction. Nm family of bioactive peptides include: Bombesin-like (NmB, NmC), kassinin-like (NmL and NmK or neurokinins A and B), neurotensin-like (NmN), and neuromedin U (NmU, for its ability to stimulate uterine muscle contraction). Besides its roles in smooth muscle contraction (human ileum, urinary bladder, rat stomach etc), NmU has also been implicated in hypertension, blood flow in intestine, and neurotransmission. Recently two structurally related, orphan G-protein coupled receptors, termed NMUR1 (GPCR66/ FM-3/SNORF62) and NMUR2 (TGR-1/FM-4/ SNORF72), have been identified as cognate receptors of NmU. NMU receptors display a typical 7 TM domains with extracellular N-terminus and intracellular C-terminus. NMUR1 is found at low levels in uterus, where NmU has robust contractile activity. Strong specific NmU binding sites have been found in uterus suggesting the presence of another NmU receptor. A novel GPCR, termed NMUR2 (FM-4/TGR-1/SNORF72) has been identified as the 2nd receptor for NmU. NMUR2 (rat 395 aa, human 415 aa, chromosome 5q31.1, ~78% homology) has approx 50% homology with NMUR1. NMUR2 also couples to Gq in the signal transduction pathway. Unlike NMUR1, NMUR2 was primarily expressed in the rat uterus and brain. Moderate to low level of expression was found in rat lung, ovary and GI-tract. In human, NMUR2 has highest expression in testing and brain. Moderate expression was also detected in kidney, lung and thyroid. Applications: Suitable for use in ELISA, Antibody Blocking. Not suitable for use in Western Blot. Other applications not tested. Recommended Dilution: ELISA: ~1:100,000 using 50-100ng control peptide/well. Antibody Blocking: 5-10ug per 1ul N2912-06 (antiserum) or per 1ug N2912-07(affinity purified antibody). Optimal dilutions to be determined by the researcher. Control Peptide: N2912-05 Storage and Stability: May be stored at 4C for short-term only. For long-term storage, store at -20C. Aliquots are stable for at least 6 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
